321 related articles for article (PubMed ID: 30425193)
21. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
[TBL] [Abstract][Full Text] [Related]
22. A novel missense mutation of Wilms' Tumor 1 causes autosomal dominant FSGS.
Hall G; Gbadegesin RA; Lavin P; Wu G; Liu Y; Oh EC; Wang L; Spurney RF; Eckel J; Lindsey T; Homstad A; Malone AF; Phelan PJ; Shaw A; Howell DN; Conlon PJ; Katsanis N; Winn MP
J Am Soc Nephrol; 2015 Apr; 26(4):831-43. PubMed ID: 25145932
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice.
Liao MC; Miyata KN; Chang SY; Zhao XP; Lo CS; El-Mortada MA; Peng J; Chenier I; Yamashita M; Ingelfinger JR; Chan JSD; Zhang SL
Clin Sci (Lond); 2022 May; 136(10):715-731. PubMed ID: 35502764
[TBL] [Abstract][Full Text] [Related]
24. Role of MiR-155 Signal Pathway in Regulating Podocyte Injury Induced by TGF-β1.
Lin X; Zhen X; Huang H; Wu H; You Y; Guo P; Gu X; Yang F
Cell Physiol Biochem; 2017; 42(4):1469-1480. PubMed ID: 28719898
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-206 and its down-regulation of Wilms'Tumor-1 dictate podocyte health in adriamycin-induced nephropathy.
Guo N; Guo J; Su D
Ren Fail; 2016 Jul; 38(6):989-95. PubMed ID: 27056206
[TBL] [Abstract][Full Text] [Related]
26. Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure.
Schwartzman M; Reginensi A; Wong JS; Basgen JM; Meliambro K; Nicholas SB; D'Agati V; McNeill H; Campbell KN
J Am Soc Nephrol; 2016 Jan; 27(1):216-26. PubMed ID: 26015453
[TBL] [Abstract][Full Text] [Related]
27. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.
Fornoni A; Sageshima J; Wei C; Merscher-Gomez S; Aguillon-Prada R; Jauregui AN; Li J; Mattiazzi A; Ciancio G; Chen L; Zilleruelo G; Abitbol C; Chandar J; Seeherunvong W; Ricordi C; Ikehata M; Rastaldi MP; Reiser J; Burke GW
Sci Transl Med; 2011 Jun; 3(85):85ra46. PubMed ID: 21632984
[TBL] [Abstract][Full Text] [Related]
28. The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis.
Schwartz MM
Ren Fail; 2000 Nov; 22(6):663-84. PubMed ID: 11104157
[TBL] [Abstract][Full Text] [Related]
29. Primary Focal Segmental Glomerulosclerosis Plasmas Increase Lipid Droplet Formation and Perilipin-2 Expression in Human Podocytes.
den Braanker DJW; Maas RJH; van Mierlo G; Parr NMJ; Bakker-van Bebber M; Deegens JKJ; Jansen PWTC; Gloerich J; Willemsen B; Dijkman HB; van Gool AJ; Wetzels JFM; Rinschen MM; Vermeulen M; Nijenhuis T; van der Vlag J
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613637
[TBL] [Abstract][Full Text] [Related]
30. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
31. Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis.
Li F; Fang Y; Zhuang Q; Cheng M; Moronge D; Jue H; Meyuhas O; Ding X; Zhang Z; Chen JK; Wu H
Kidney Int; 2022 Jul; 102(1):121-135. PubMed ID: 35483522
[TBL] [Abstract][Full Text] [Related]
32. Asparagine endopeptidase protects podocytes in adriamycin-induced nephropathy by regulating actin dynamics through cleaving transgelin.
Qiu Y; Lei C; Zeng J; Xie Y; Cao Y; Yuan Q; Su H; Zhang Z; Zhang C
Mol Ther; 2023 Nov; 31(11):3337-3354. PubMed ID: 37689970
[TBL] [Abstract][Full Text] [Related]
33. Activation of necroptosis pathway in podocyte contributes to the pathogenesis of focal segmental glomerular sclerosis.
Hu H; Li M; Chen B; Guo C; Yang N
Clin Exp Nephrol; 2022 Nov; 26(11):1055-1066. PubMed ID: 35925422
[TBL] [Abstract][Full Text] [Related]
34. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
[TBL] [Abstract][Full Text] [Related]
35. Podocyte RNA sequencing reveals Wnt- and ECM-associated genes as central in FSGS.
Bukosza EN; Kratochwill K; Kornauth C; Schachner H; Aufricht C; Gebeshuber CA
PLoS One; 2020; 15(4):e0231898. PubMed ID: 32302353
[TBL] [Abstract][Full Text] [Related]
36. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T
J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
[TBL] [Abstract][Full Text] [Related]
37. Podocyte-associated gene mutation screening in a heterogeneous cohort of patients with sporadic focal segmental glomerulosclerosis.
Laurin LP; Lu M; Mottl AK; Blyth ER; Poulton CJ; Weck KE
Nephrol Dial Transplant; 2014 Nov; 29(11):2062-9. PubMed ID: 24500309
[TBL] [Abstract][Full Text] [Related]
38. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.
Kim JS; Han BG; Choi SO; Cha SK
Biomed Res Int; 2016; 2016():1630365. PubMed ID: 27088082
[TBL] [Abstract][Full Text] [Related]
39. CircZNF609 is involved in the pathogenesis of focal segmental glomerulosclerosis by sponging miR-615-5p.
Cui X; Fu J; Luan J; Qi H; Jiao C; Ran M; Wang D; Hao X; Zhang Y; Kopp JB; Pi J; Zhou H
Biochem Biophys Res Commun; 2020 Oct; 531(3):341-349. PubMed ID: 32800553
[TBL] [Abstract][Full Text] [Related]
40. TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.
Sakairi T; Abe Y; Kopp JB
Nephrol Dial Transplant; 2011 Sep; 26(9):2746-52. PubMed ID: 21378152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
